Table 3.
Analysis of demographic characteristics and bladder outcomes of women undergoing pelvic floor reconstructive surgery, stratified by hysterectomy status
| Reconstructive surgery with previous hysterectomy | Reconstructive surgery with concomitant hysterectomy | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Sacrocolpopexy | Sacrospinous suspension | p value | Total | Uterosacral suspension | Sacrospinous suspension | p value | ||
| Total | 308 |
105 (34.1%, 29.0–39.6%) |
203 (65.9%, 60.4–71.0%) |
364 |
228 (62.6%, 57.5–67.5%) |
136 (37.4%, 32.5–42.5%) |
|||
| Age (years) |
Mean (95%CI) |
64.5 (63.3–65.7) |
63.5 (61.8–65.3) |
65.0 (63.5–66.6) |
0.377 |
60.2 (59.1–61.4) |
59.4 (57.9–60.9) |
61.5 (59.9–63.2) |
0.254 |
| Median (IQR) |
65 (57.5–72) |
63 (57–71) |
66 (58–73) |
62 (53–69) |
61 (51–68) |
62 (55–69) |
|||
| Length of stay (days) |
Mean (95%CI) |
2.8 (0.5–5.1) |
1.8 (1.4–2.1) |
3.3 (0.0–6.9) |
0.622 |
1.8 (1.6–2.0) |
1.7 (1.5–1.9) |
1.8 (1.6–2.1) |
0.524 |
| Median (IQR) |
1 (1–2) |
1 (1–2) |
1 (1–2) |
2 (1–2) |
1 (1–2) |
1 (1–2) |
|||
| Number of voids to pass bladder protocol |
Mean (95%CI) |
2.8 (2.5–3.0) |
2.7 (2.4–3.0) |
2.8 (2.4–3.1) |
0.439 |
3.4 (3.1–3.7) |
3.4 (3.0–3.9) |
3.6 (3.1–4.1) |
0.056 |
| Median (IQR) |
2 (2–3) |
2 (2–3) |
2 (2–3) |
2 (2–4) |
2 (2–4) |
3 (2–4) |
|||
| Patients who went home with a catheter | N | 78 | 23 | 55 | 0.321 | 119 | 79 | 40 | 0.303 |
|
Proportion (95%CI) |
25.3% (20.8–30.5%) | 21.9% (15.0–30.9%) | 27.1% (21.4–33.6%) | 32.7% (28.1–37.7%) | 34.6% (28.7–41.1%) | 29.4% (22.3–37.7%) | |||
| Elevated PVR after second void | N | 146 | 50 | 96 | 0.896 | 223 | 137 | 86 | 0.551 |
| Proportion (95%CI) | 48.6% (42.0–53.2%) |
48.1% (38.2–58.1%) |
47.3% (40.3–54.4%) |
61.3% (56.1–66.2%) |
60.1% (53.4–66.5%) |
63.2% (54.5–71.3%) |
|||
| Crude Odds Ratio (95%CI) | - |
1.0 (0.6–1.7) |
Reference | - |
0.9 (0.6–1.4) |
Reference | |||
| Elevated PVR after third void | N | 116 | 39 | 77 | 0.941 | 189 | 120 | 69 | 0.726 |
| Proportion (95%CI) |
37.8% (32.5–43.4%) |
37.5% (28.2–47.5%) |
37.9% (31.2–45.0%) |
51.9% (46.8–57.0%) |
52.6% (45.9–59.3%) |
50.7% (42.0–59.4%) |
|||
| Crude Odds Ratio (95%CI) | - |
0.98 (0.6–1.6) |
Reference | - |
1.1 (0.7–1.7) |
Reference | |||
The uterosacral suspension group for those with previous hysterectomy and the sacrocolpopexy for those with concomitant hysterectomy were excluded because of small sample size. Some values may not add to 100% due to missing values